Fig. 1From: Utility of in vitro release testing (IVRT) to assess ‘sameness’ of 1% clotrimazole creams for use as a biowaiverRelease rate profiles comparing comparator product, Canesten.® vs. itself (R1a and R1b) (n = 6)Back to article page